{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:50:13Z","timestamp":1793713813704,"version":"4.6.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["U19AG069701"],"award-info":[{"award-number":["U19AG069701"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG071226"],"award-info":[{"award-number":["R01AG071226"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG068034"],"award-info":[{"award-number":["R01AG068034"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG057181"],"award-info":[{"award-number":["R01AG057181"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG081203"],"award-info":[{"award-number":["RF1AG081203"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["A2021015F"],"award-info":[{"award-number":["A2021015F"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-026-04002-9","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:35:41Z","timestamp":1774960541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Astrocytic APOE3-Christchurch expression ameliorates brain amyloid-\u03b2 pathology in 5xFAD mice"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5044-9197","authenticated-orcid":false,"given":"Ana-Caroline","family":"Raulin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla","family":"Alnobani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Rodriguez-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunmi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Linares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aria R.","family":"Yslas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxue","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney V.","family":"Doss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey A.","family":"Kuchenbecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka A.","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7203-3926","authenticated-orcid":false,"given":"Chia-Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3491-1016","authenticated-orcid":false,"given":"Guojun","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6751-9374","authenticated-orcid":false,"given":"Takahisa","family":"Kanekiyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"4002_CR1","doi-asserted-by":"crossref","unstructured":"Alzheimer's Association. Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2024;20:3708-1.","DOI":"10.1002\/alz.13809"},{"key":"4002_CR2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"AC Raulin","year":"2022","unstructured":"Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu CC. ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol Neurodegener. 2022;17:72.","journal-title":"Mol Neurodegener"},{"key":"4002_CR3","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","volume":"25","author":"JF Arboleda-Velasquez","year":"2019","unstructured":"Arboleda-Velasquez JF, Lopera F, O\u2019Hare M, Delgado-Tirado S, Marino C, Chmielewska N, et al. Resistance to autosomal dominant Alzheimer\u2019s disease in an APOE3 Christchurch homozygote: a case report. Nat Med. 2019;25:1680\u20133.","journal-title":"Nat Med"},{"key":"4002_CR4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2023.11.029","volume":"187","author":"Y Chen","year":"2024","unstructured":"Chen Y, Song S, Parhizkar S, Lord J, Zhu Y, Strickland MR, et al. APOE3ch alters microglial response and suppresses Abeta-induced tau seeding and spread. Cell. 2024;187:428\u2013445.e420.","journal-title":"Cell"},{"key":"4002_CR5","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1016\/j.ymthe.2024.11.003","volume":"32","author":"C Gunaydin","year":"2024","unstructured":"Gunaydin C, Sondhi D, Kaminsky SM, Lephart HC, Leopold PL, Hackett NR, et al. AAVrh.10 delivery of novel APOE2-Christchurch variant suppresses amyloid and Tau pathology in Alzheimer\u2019s disease mice. Mol Ther. 2024;32:4303\u201318.","journal-title":"Mol Ther"},{"key":"4002_CR6","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1038\/s41593-023-01480-8","volume":"26","author":"MR Nelson","year":"2023","unstructured":"Nelson MR, Liu P, Agrawal A, Yip O, Blumenfeld J, Traglia M, et al. The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation. Nat Neurosci. 2023;26:2104\u201321.","journal-title":"Nat Neurosci"},{"key":"4002_CR7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13024-024-00793-x","volume":"20","author":"KM Tran","year":"2025","unstructured":"Tran KM, Kwang NE, Butler CA, Gomez-Arboledas A, Kawauchi S, Mar C, et al. APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology. Mol Neurodegener. 2025;20:9.","journal-title":"Mol Neurodegener"},{"key":"4002_CR8","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1146\/annurev-biochem-032620-104801","volume":"91","author":"AC Raulin","year":"2022","unstructured":"Raulin AC, Martens YA, Bu G. Lipoproteins in the central nervous system: from biology to pathobiology. Annu Rev Biochem. 2022;91:731\u201359.","journal-title":"Annu Rev Biochem"},{"key":"4002_CR9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1046-2023(02)00220-7","volume":"28","author":"S Zolotukhin","year":"2002","unstructured":"Zolotukhin S, Potter M, Zolotukhin I, Sakai Y, Loiler S, Fraites TJ Jr., et al. Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods. 2002;28:158\u201367.","journal-title":"Methods"},{"key":"4002_CR10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13024-015-0001-3","volume":"10","author":"J Hu","year":"2015","unstructured":"Hu J, Liu CC, Chen XF, Zhang YW, Xu H, Bu G. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Abeta metabolism in apoE4-targeted replacement mice. Mol Neurodegener. 2015;10:6.","journal-title":"Mol Neurodegener"},{"key":"4002_CR11","doi-asserted-by":"crossref","first-page":"110961","DOI":"10.1016\/j.celrep.2022.110961","volume":"39","author":"S Kiani Shabestari","year":"2022","unstructured":"Kiani Shabestari S, Morabito S, Danhash EP, McQuade A, Sanchez JR, Miyoshi E, et al. Absence of microglia promotes diverse pathologies and early lethality in Alzheimer\u2019s disease mice. Cell Rep. 2022;39:110961.","journal-title":"Cell Rep"},{"key":"4002_CR12","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.stem.2022.11.004","volume":"29","author":"CB Pantazis","year":"2022","unstructured":"Pantazis CB, Yang A, Lara E, McDonough JA, Blauwendraat C, Peng L, et al. A reference human induced pluripotent stem cell line for large-scale collaborative studies. Cell Stem Cell. 2022;29:1685\u20131702.e1622.","journal-title":"Cell Stem Cell"},{"key":"4002_CR13","doi-asserted-by":"crossref","DOI":"10.1038\/s41597-021-01054-y","volume":"8","author":"S Forner","year":"2021","unstructured":"Forner S, Kawauchi S, Balderrama-Gutierrez G, Kramar EA, Matheos DP, Phan J, et al. Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer\u2019s disease. Sci Data. 2021;8:270.","journal-title":"Sci Data"},{"key":"4002_CR14","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.celrep.2016.06.060","volume":"16","author":"T Liebmann","year":"2016","unstructured":"Liebmann T, Renier N, Bettayeb K, Greengard P, Tessier-Lavigne M, Flajolet M. Three-Dimensional study of Alzheimer\u2019s disease hallmarks using the iDISCO clearing method. Cell Rep. 2016;16:1138\u201352.","journal-title":"Cell Rep"},{"key":"4002_CR15","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1016\/j.cell.2022.09.030","volume":"185","author":"H Ennerfelt","year":"2022","unstructured":"Ennerfelt H, Frost EL, Shapiro DA, Holliday C, Zengeler KE, Voithofer G, et al. SYK coordinates neuroprotective microglial responses in neurodegenerative disease. Cell. 2022;185:4135\u20134152.e4122.","journal-title":"Cell"},{"key":"4002_CR16","doi-asserted-by":"crossref","first-page":"e27037","DOI":"10.1371\/journal.pone.0027037","volume":"6","author":"D Georgiadou","year":"2011","unstructured":"Georgiadou D, Chroni A, Vezeridis A, Zannis VI, Stratikos E. Biophysical analysis of apolipoprotein E3 variants linked with development of type III hyperlipoproteinemia. PLoS One. 2011;6:e27037.","journal-title":"PLoS One"},{"key":"4002_CR17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cell.2024.10.027","volume":"188","author":"JL Guo","year":"2025","unstructured":"Guo JL, Braun D, Fitzgerald GA, Hsieh YT, Rouge L, Litvinchuk A, et al. Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes. Cell. 2025;188:187\u2013206.e126.","journal-title":"Cell"},{"key":"4002_CR18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.immuni.2024.11.024","volume":"58","author":"S Kaji","year":"2025","unstructured":"Kaji S, Berghoff SA, Spieth L, Schlaphoff L, Sasmita AO, Vitale S, et al. Apolipoprotein E aggregation in microglia initiates Alzheimer\u2019s disease pathology by seeding beta-amyloidosis. Immunity. 2025;58:263.","journal-title":"Immunity"},{"key":"4002_CR19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13024-022-00516-0","volume":"17","author":"TE Mahan","year":"2022","unstructured":"Mahan TE, Wang C, Bao X, Choudhury A, Ulrich JD, Holtzman DM. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Abeta accumulation and plaque-related pathology in a mouse model of amyloidosis. Mol Neurodegener. 2022;17:13.","journal-title":"Mol Neurodegener"},{"key":"4002_CR20","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1023\/A:1021910729963","volume":"22","author":"H Akiyama","year":"1997","unstructured":"Akiyama H, Mori H, Sahara N, Kondo H, Ikeda K, Nishimura T, et al. Variable deposition of amyloid beta-protein (A beta) with the carboxy-terminus that ends at residue valine40 (A beta 40) in the cerebral cortex of patients with Alzheimer\u2019s disease: a double-labeling immunohistochemical study with antibodies specific for A beta 40 and the A beta that ends at residues alanine42\/threonine43 (A beta 42). Neurochem Res. 1997;22:1499\u2013506.","journal-title":"Neurochem Res"},{"key":"4002_CR21","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.3390\/ijms23094972","volume":"23","author":"P Marazuela","year":"2022","unstructured":"Marazuela P, Paez-Montserrat B, Bonaterra-Pastra A, Sole M, Hernandez-Guillamon M. Impact of cerebral amyloid angiopathy in two transgenic mouse models of cerebral beta-Amyloidosis: A neuropathological study. Int J Mol Sci. 2022;23:4972.","journal-title":"Int J Mol Sci"},{"key":"4002_CR22","doi-asserted-by":"crossref","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, Patterson BW, et al. Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci Transl Med. 2011;3:89ra57.","journal-title":"Sci Transl Med"},{"key":"4002_CR23","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","volume":"96","author":"CC Liu","year":"2017","unstructured":"Liu CC, Zhao N, Fu Y, Wang N, Linares C, Tsai CW, et al. ApoE4 Accelerates early seeding of amyloid pathology. Neuron. 2017;96:1024\u20131032.e1023.","journal-title":"Neuron"},{"key":"4002_CR24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.neuron.2024.12.015","volume":"113","author":"G Chen","year":"2025","unstructured":"Chen G, Wang M, Zhang Z, Hong DK, Ahn EH, Liu X, et al. ApoE3 R136S binds to Tau and blocks its propagation, suppressing neurodegeneration in mice with Alzheimer\u2019s disease. Neuron. 2025;113:719\u2013736.e715.","journal-title":"Neuron"},{"key":"4002_CR25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","volume":"15","author":"I Benilova","year":"2012","unstructured":"Benilova I, Karran E, De Strooper B. The toxic Abeta oligomer and Alzheimer\u2019s disease: an emperor in need of clothes. Nat Neurosci. 2012;15:349\u201357.","journal-title":"Nat Neurosci"},{"key":"4002_CR26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53415-8","volume":"9","author":"T Ochiishi","year":"2019","unstructured":"Ochiishi T, Kaku M, Kiyosue K, Doi M, Urabe T, Hattori N, et al. New Alzheimer\u2019s disease model mouse specialized for analyzing the function and toxicity of intraneuronal Amyloid beta oligomers. Sci Rep. 2019;9:17368.","journal-title":"Sci Rep"},{"key":"4002_CR27","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, et al. Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med. 2008;14:837\u201342.","journal-title":"Nat Med"},{"key":"4002_CR28","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-05153-5","volume":"13","author":"A Ajoolabady","year":"2022","unstructured":"Ajoolabady A, Lindholm D, Ren J, Pratico D. ER stress and UPR in Alzheimer\u2019s disease: mechanisms, pathogenesis, treatments. Cell Death Dis. 2022;13:706.","journal-title":"Cell Death Dis"},{"key":"4002_CR29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/09727531211070528","volume":"29","author":"G Beretta","year":"2022","unstructured":"Beretta G, Shala AL. Impact of heat shock proteins in neurodegeneration: possible therapeutical targets. Ann Neurosci. 2022;29:71\u201382.","journal-title":"Ann Neurosci"},{"key":"4002_CR30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13195-014-0078-x","volume":"6","author":"X Zhang","year":"2014","unstructured":"Zhang X, Shi J, Tian J, Robinson AC, Davidson YS, Mann DM. Expression of one important chaperone protein, heat shock protein 27, in neurodegenerative diseases. Alzheimers Res Ther. 2014;6:78.","journal-title":"Alzheimers Res Ther"},{"key":"4002_CR31","volume":"52","author":"X Han","year":"2022","unstructured":"Han X, Liu Y, Dai Y, Xu T, Hu Q, Yi X, et al. Neuronal SH2B1 attenuates apoptosis in an MPTP mouse model of Parkinson\u2019s disease via promoting PLIN4 degradation. Redox Biol. 2022;52:102308.","journal-title":"Redox Biol"},{"key":"4002_CR32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3389\/fnins.2018.00397","volume":"12","author":"X Han","year":"2018","unstructured":"Han X, Zhu J, Zhang X, Song Q, Ding J, Lu M, et al. Plin4-Dependent lipid droplets hamper neuronal mitophagy in the MPTP\/p-Induced mouse model of Parkinson\u2019s disease. Front Neurosci. 2018;12:397.","journal-title":"Front Neurosci"},{"key":"4002_CR33","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-58634-4","volume":"16","author":"A Rezaei","year":"2025","unstructured":"Rezaei A, Kocsis-Jutka V, Gunes ZI, Zeng Q, Kislinger G, Bauernschmitt F, et al. Correction of dysregulated lipid metabolism normalizes gene expression in oligodendrocytes and prolongs lifespan in female poly-GA C9orf72 mice. Nat Commun. 2025;16:3442.","journal-title":"Nat Commun"},{"key":"4002_CR34","volume":"18","author":"Y Cao","year":"2024","unstructured":"Cao Y, Zhao LW, Chen ZX, Li SH. New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer\u2019s disease. Front Neurosci. 2024;18:1430465.","journal-title":"Front Neurosci"},{"key":"4002_CR35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-025-00803-6","volume":"20","author":"S He","year":"2025","unstructured":"He S, Xu Z, Han X. Lipidome disruption in Alzheimer\u2019s disease brain: detection, pathological mechanisms, and therapeutic implications. Mol Neurodegener. 2025;20:11.","journal-title":"Mol Neurodegener"},{"key":"4002_CR36","volume":"9","author":"H Ma","year":"2022","unstructured":"Ma H, Dong Y, Chu Y, Guo Y, Li L. The mechanisms of ferroptosis and its role in alzheimer\u2019s disease. Front Mol Biosci. 2022;9:965064.","journal-title":"Front Mol Biosci"},{"key":"4002_CR37","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-024-07152-0","volume":"15","author":"N Majernikova","year":"2024","unstructured":"Majernikova N, Marmolejo-Garza A, Salinas CS, Luu MDA, Zhang Y, Trombetta-Lima M, et al. The link between amyloid beta and ferroptosis pathway in Alzheimer\u2019s disease progression. Cell Death Dis. 2024;15:782.","journal-title":"Cell Death Dis"},{"key":"4002_CR38","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.21037\/tcr-23-2046","volume":"13","author":"R Zhao","year":"2024","unstructured":"Zhao R, Chen Q, Qiao P, Lu Y, Chen X. A signature of four ferroptosis-related genes in laryngeal squamous cell carcinoma. Transl Cancer Res. 2024;13:2938\u201349.","journal-title":"Transl Cancer Res"},{"key":"4002_CR39","volume":"76","author":"XD Zhang","year":"2024","unstructured":"Zhang XD, Sun J, Zheng XM, Zhang J, Tan LL, Fan LL, et al. Plin4 exacerbates cadmium-decreased testosterone level via inducing ferroptosis in testicular Leydig cells. Redox Biol. 2024;76:103312.","journal-title":"Redox Biol"},{"key":"4002_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2024.08.001","volume":"105","author":"F Zeng","year":"2024","unstructured":"Zeng F, Zhou M, Li Q, Hu H, Chen C. Sevoflurane promotes neuronal ferroptosis via upregulation of PLIN4 to modulate the hippo signaling pathway. Neurotoxicology. 2024;105:1\u20139.","journal-title":"Neurotoxicology"},{"key":"4002_CR41","volume":"43","author":"GG Sun","year":"2024","unstructured":"Sun GG, Wang C, Mazzarino RC, Perez-Corredor PA, Davtyan H, Blurton-Jones M, et al. Microglial APOE3 Christchurch protects neurons from Tau pathology in a human iPSC-based model of Alzheimer\u2019s disease. Cell Rep. 2024;43:114982.","journal-title":"Cell Rep"},{"key":"4002_CR42","doi-asserted-by":"crossref","unstructured":"Naguib S, Lopez-Lee C, Torres ER, Lee SI, Zhu J, Zhu D, et al. APOE3-R136S mutation confers resilience against tau pathology via cGAS-STING-IFN inhibition. bioRxiv. 2025.","DOI":"10.2139\/ssrn.4799775"},{"key":"4002_CR43","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","volume":"141","author":"NJ Ashton","year":"2021","unstructured":"Ashton NJ, Pascoal TA, Karikari TK, Benedet AL, Lantero-Rodriguez J, Brinkmalm G, et al. Plasma p-tau231: a new biomarker for incipient Alzheimer\u2019s disease pathology. Acta Neuropathol. 2021;141:709\u201324.","journal-title":"Acta Neuropathol"},{"key":"4002_CR44","doi-asserted-by":"crossref","first-page":"15233","DOI":"10.1073\/pnas.96.26.15233","volume":"96","author":"KR Bales","year":"1999","unstructured":"Bales KR, Verina T, Cummins DJ, Du Y, Dodel RC, Saura J, et al. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 1999;96:15233\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4002_CR45","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","volume":"97","author":"DM Holtzman","year":"2000","unstructured":"Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2000;97:2892\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4002_CR46","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1084\/jem.20171265","volume":"215","author":"JD Ulrich","year":"2018","unstructured":"Ulrich JD, Ulland TK, Mahan TE, Nystrom S, Nilsson KP, Song WM, et al. ApoE facilitates the microglial response to amyloid plaque pathology. J Exp Med. 2018;215:1047\u201358.","journal-title":"J Exp Med"},{"key":"4002_CR47","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1172\/JCI6179","volume":"103","author":"DM Holtzman","year":"1999","unstructured":"Holtzman DM, Bales KR, Wu S, Bhat P, Parsadanian M, Fagan AM, et al. Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer\u2019s disease. J Clin Invest. 1999;103:R15\u2013R21.","journal-title":"J Clin Invest"},{"key":"4002_CR48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-016-1558-9","volume":"132","author":"KR Sadleir","year":"2016","unstructured":"Sadleir KR, Kandalepas PC, Buggia-Prevot V, Nicholson DA, Thinakaran G, Vassar R. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Abeta generation in Alzheimer\u2019s disease. Acta Neuropathol. 2016;132:235\u201356.","journal-title":"Acta Neuropathol"},{"key":"4002_CR49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nm.4443","volume":"24","author":"Z He","year":"2018","unstructured":"He Z, Guo JL, McBride JD, Narasimhan S, Kim H, Changolkar L, et al. Amyloid-beta plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med. 2018;24:29\u201338.","journal-title":"Nat Med"},{"key":"4002_CR50","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1056\/NEJMoa2308583","volume":"390","author":"YT Quiroz","year":"2024","unstructured":"Quiroz YT, Aguillon D, Aguirre-Acevedo DC, Vasquez D, Zuluaga Y, Baena AY, et al. APOE3 Christchurch heterozygosity and autosomal dominant Alzheimer\u2019s disease. N Engl J Med. 2024;390:2156\u201364.","journal-title":"N Engl J Med"},{"key":"4002_CR51","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.neurobiolaging.2007.02.029","volume":"29","author":"FG De Felice","year":"2008","unstructured":"De Felice FG, Wu D, Lambert MP, Fernandez SJ, Velasco PT, Lacor PN, et al. Alzheimer\u2019s disease-type neuronal tau hyperphosphorylation induced by A beta oligomers. Neurobiol Aging. 2008;29:1334\u201347.","journal-title":"Neurobiol Aging"},{"key":"4002_CR52","doi-asserted-by":"crossref","first-page":"11938","DOI":"10.1523\/JNEUROSCI.2357-10.2010","volume":"30","author":"H Zempel","year":"2010","unstructured":"Zempel H, Thies E, Mandelkow E, Mandelkow EM. Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J Neurosci. 2010;30:11938\u201350.","journal-title":"J Neurosci"},{"key":"4002_CR53","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00401-024-02839-2","volume":"149","author":"S Kadamangudi","year":"2024","unstructured":"Kadamangudi S, Marcatti M, Zhang WR, Fracassi A, Kayed R, Limon A, et al. Amyloid-beta oligomers increase the binding and internalization of tau oligomers in human synapses. Acta Neuropathol. 2024;149:2.","journal-title":"Acta Neuropathol"},{"key":"4002_CR54","volume":"27","author":"N Wang","year":"2024","unstructured":"Wang N, Cai L, Pei X, Lin Z, Huang L, Liang C, et al. Microglial apolipoprotein E particles contribute to neuronal senescence and synaptotoxicity. iScience. 2024;27:110006.","journal-title":"iScience"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04002-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04002-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04002-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:03:39Z","timestamp":1774969419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04002-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4002"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-04002-9","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.B. serves as a consultant for SciNeuro Pharmaceuticals. Y.A.M. is a current employee of SciNeuro Pharmaceuticals. C.-C.L. is a current employee of Simcere Innovation Center. All other authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study did not include human participants or human tissue and therefore does not need informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"224"}}